MENU
UPB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Upstream Bio (UPB) Ownership - Who owns Upstream Bio?

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.64B
P/E Ratio
N/A
Total Cash
372.43M
Projected Growth
N/A
Total Debt
1.42M
Revenue
2.8M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.89
Total Debt/Equity
N/A
Revenue/Share
0.05 USD as % of share price

Fundamentals

UPB
Capitalization
1.64B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
372M
Total Cash/Share
6.89
Total Debt
1.42M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.05%
Revenue
2.8M
ROE
N/A
Book Value
379M
P/B Ratio
4.32
Cash Flow
N/A
Earnings
-6.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
56K
Current Ratio
32.67
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-140.33M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-39.36
Shares Held By Institutions
1.19B
Shares Outstanding - Current
54M
Total Liabilities
12.6M
Total Volume MTD
N/A
Value
-1
Gain YTD
84.124
View a ticker or compare two or three
UPB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details